Prediction of rectal lymph node metastasis by pelvic computed tomography measurement

European Journal of Surgical Oncology

Volumn 35, Issue 2, 2009, Pages 168-173

  Pomerri, F ^a   Maretto, I ^b   Pucciarelli, S ^b   Rugge, M ^a   Burzi, S ^a   Zandona M ^a   Ambrosi, A ^b   Urso, E ^b   Muzzio, P C ^a   Nitti, D ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Computed tomography; Lymph node status; Rectal cancer staging

Indexed keywords

CARBOPLATIN; FLUOROURACIL; FOLINIC ACID; IOHEXOL; OXALIPLATIN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECTAL LYMPH NODE METASTASIS; RECTUM CANCER; SENSITIVITY AND SPECIFICITY;

ABDOMEN; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58249097606     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.02.006     Document Type: Article

References (43)

1. Greene F.L., Page D.L., Fleming I.D., et al. AJCC American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. (2002), Springer, New York
2. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
3. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
4. Bipat S., Glas A.S., Slors F.J.M., et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 232 (2004) 773-783
5. Beets-Tan R.G., and Beets G.L. Rectal cancer: review with emphasis on MR imaging. Radiology 232 (2004) 335-346
6. Goh V., Halligan S., and Bartram C.I. Local radiological staging of rectal cancer. Clin Radiol 59 (2004) 215-226
7. Skandarajah A.R., and Tjandra J.J. Preoperative loco-regional imaging in rectal cancer. Aust NZ J Surg 76 (2006) 497-504
8. Kotanagy H., Fukuoka T., Shibata Y., et al. The size of regional lymph nodes does not correlate with the presence or absence of metastases in lymph nodes in rectal cancer. J Surg Oncol 54 (1993) 252-254
9. Brown G., Richards C.J., Bourne M.W., et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227 (2003) 371-377
10. Kim J.H., Beets G.L., Kim M.J., et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol 52 (2004) 78-83
11. Minsky B.D., Cohen A.M., Kemeny N., et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 10 (1992) 1218-1224
12. Pucciarelli S., Friso M.L., Toppan P., et al. Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results. Ann Surg Oncol 7 (2000) 38-44
13. Theodoropoulos G., Wise W.E., Padmanabhan A., et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45 (2002) 895-903
14. Chan A.K.P., Wong A.O., Langevin J., et al. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival. Int J Radiat Oncol Biol Phys 37 (1997) 629-637
15. Mohiuddin M., Regine W.F., John W.J., et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 46 (2000) 883-888
16. Gerard J.P., Chapet O., Nemoz C., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 22 (2004) 2404-2409
17. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., Michalski W., Bebenek M., and Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
18. Das P., Skibber J.M., Rodriguez-Bigas M.A., et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109 (2007) 1750-1755
19. Bedrosian I., Rodriguez-Bigas M.A., Feig B., et al. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 8 (2004) 56-62
20. Stipa F., Zernecke A., Moore H.G., et al. Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?. Ann Surg Oncol 11 (2004) 187-191
21. Read T.E., Andujar J.E., Caushaj P.F., et al. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 47 (2004) 825-831
22. Pucciarelli S., Capirci C., Emanuele U., et al. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 12 (2005) 111-116
23. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240 (2004) 711-717
24. Kim C.J., Yeatman T.J., Coppola D., et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 234 (2001) 352-358
25. Schell S.R., Zlotecki R.A., Mendenhall W.M., et al. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 194 (2002) 584-590
26. Bonnen M., Crane C., Vauthey J.N., et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60 (2004) 1098-1105
27. Blomqvist L., Holm T., Nyren S., et al. MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin Radiol 57 (2002) 211-218
28. Kim N.K., Kim M.J., Yun S.H., et al. Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum 42 (1999) 770-775
29. Chiesura-Corona M., Muzzio P.C., Giust G., et al. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging 26 (2001) 134-138
30. Harewood G.C., Wiersma M.J., Nelson H., et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 123 (2002) 24-32
31. Pucciarelli S., Toppan P., Friso M.L., et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 47 (2004) 1798-1807
32. Enker E.W., Thaler T.H., Cranon L.M., et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181 (1995) 335-346
33. MacFarlane J.K., Ryall R.D., and Heald R.J. Mesorectal excision for rectal cancer. Lancet 341 (1993) 457-460
34. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2 8514 (1986) 996-999
35. Herbst F. Pelvic radiological imaging: a surgeon's perspective. Eur J Radiol 47 (2003) 135-141
36. Brown G., Radcliffe A.G., Newcombe R.G., Dallimore N.S., Bourne M.W., and Williams G.T. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90 (2003) 355-364
37. Kim C.K., Kim S.H., Chun H.K., et al. Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol 16 (2006) 972-980
38. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
39. Ratto C., Ricci R., Rossi C., et al. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 45 (2002) 733-742
40. Kahn H., Alexander A., Rakinic J., et al. Preoperative staging of irradiated rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound, and magnetic resonance imaging does not accurately predict T0,N0 pathology. Dis Colon Rectum 40 (1997) 140-144
41. Rau B., Hunerbein M., Barth C., et al. Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg Endosc 13 (1999) 980-984
42. Denecke T., Rau B., Hoffmann K.T., et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?. Eur Radiol 15 (2005) 1658-1666
43. Maretto I., Pomerri F., Pucciarelli S., et al. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 14 (2007) 455-461